Skip to main content
Livermore
Livermore
ZHEN

Perceptive Advisors LLC

SEC CIK
0001224962
Latest filing
Aug 14, 2026

Holdings in Q2 2021

Holdings as of Jun 30, 2021, filed Aug 17, 2021. Long positions only; changes compare share counts with Q1 2021.

Institution overview
Positions
148
+12 vs. Q1 2021
Portfolio value
$7.69B
+$165.9M (+2.2%) vs. Q1 2021
Filed
Aug 17, 2021
AmendedSEC
Holdings of Perceptive Advisors LLC in Q2 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
VRCAVerrica Pharmaceuticals Inc.COM3,610,412$40.8M0.5%00.0%UnchangedHistory
APLSApellis Pharmaceuticals, Inc.COM661,162$41.8M0.5%+661,162NewHistory
DBVTDBV Technologies S.A.SPONSORED ADR7,695,505$42.0M0.5%00.0%UnchangedHistory
CMAXCareMax, Inc.COM CL A3,320,000$42.8M0.6%+3,320,000NewHistory
Coherus Biosciences Inc19249HAB9NOTE 1.500% 4/1–$46.1M0.6%–New–
AVIRAtea Pharmaceuticals, Inc.COM2,259,224$48.5M0.6%−850,000−27.3%ReducedHistory
SLDBSolid Biosciences Inc.COM13,412,552$49.1M0.6%00.0%UnchangedHistory
MORFMorphic Holding, Inc.COM938,140$53.8M0.7%00.0%UnchangedHistory
MDTMedtronic plcStock450,000$55.9M0.7%+450,000NewHistory
MGNXMacrogenics IncCOM2,148,060$57.7M0.8%00.0%UnchangedHistory
QTNTQuotient LtdSHS16,200,818$59.0M0.8%00.0%UnchangedHistory
KRONKronos Bio, Inc.COM2,528,052$60.5M0.8%−252,045−9.1%ReducedHistory
KDMNKadmon Holdings, Inc.COM15,711,334$60.8M0.8%00.0%UnchangedHistory
ESTAEstablishment Labs Holdings Inc.COM700,408$61.2M0.8%−286,879−29.1%ReducedHistory
ATNXAthenex, Inc.COM13,532,467$62.5M0.8%00.0%UnchangedHistory
CHRSCoherus Oncology, Inc.COM4,697,612$65.0M0.8%00.0%UnchangedHistory
ZYZymergen Inc.COM1,633,332$65.3M0.8%+1,633,332NewHistory
BEAMBeam Therapeutics Inc.COM537,635$69.2M0.9%00.0%UnchangedHistory
RLAYRelay Therapeutics, Inc.COM2,018,097$73.8M1.0%00.0%UnchangedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM3,963,517$74.7M1.0%+304,136+8.3%AddedHistory
RAPTRAPT Therapeutics, Inc.COM2,475,660$78.7M1.0%−1,821−0.1%ReducedHistory
NBIXNeurocrine Biosciences IncStock811,832$79.0M1.0%−130,000−13.8%ReducedHistory
RXDXPrometheus Biosciences, Inc.COM3,314,032$81.4M1.1%00.0%UnchangedHistory
ALBOAlbireo Pharma, Inc.COM2,360,139$83.0M1.1%00.0%UnchangedHistory
OMICSingular Genomics Systems, Inc.COM3,082,870$84.7M1.1%+3,082,870NewHistory
CCCCC4 Therapeutics, Inc.COM STK2,258,566$85.5M1.1%−900,000−28.5%ReducedHistory
NAUTNautilus Biotechnology, Inc.COM8,911,151$90.0M1.2%+8,911,151NewHistory
MGTXMeiraGTx Holdings plcCOM6,948,277$107.7M1.4%+15,000+0.2%AddedHistory
UTHRUnited Therapeutics CorpCOM616,802$110.7M1.4%+441,802+252.5%AddedHistory
ALDXAldeyra Therapeutics, Inc.COM9,903,879$112.2M1.5%+1,200,000+13.8%AddedHistory
CERECerevel Therapeutics Holdings, Inc.COM4,643,095$119.0M1.5%00.0%UnchangedHistory
OMOutset Medical, Inc.COM2,387,535$119.3M1.6%00.0%UnchangedHistory
RCKTRocket Pharmaceuticals, Inc.COM2,751,603$121.9M1.6%−116,168−4.1%ReducedHistory
NVRONevro CorpCOM818,760$135.7M1.8%+6,606+0.8%AddedHistory
GBTGlobal Blood Therapeutics, Inc.COM4,152,689$145.4M1.9%−905,953−17.9%ReducedHistory
ZYMEZymeworks Inc.COM4,305,600$149.4M1.9%−25,268−0.6%ReducedHistory
Nevro Corp64157FAC7NOTE 2.750% 4/0–$156.3M2.0%–––
NVTAInvitae CorpCOM4,818,801$162.5M2.1%−541,872−10.1%ReducedHistory
LABPLandos Biopharma, Inc.COM14,869,915$171.7M2.2%00.0%UnchangedHistory
VBIVVBI Vaccines Inc/BCCOM NEW55,042,465$184.4M2.4%00.0%UnchangedHistory
HZNPHorizon Therapeutics Public Ltd CoSHS1,985,002$185.9M2.4%−65,000−3.2%ReducedHistory
Collegium Pharmaceutical, Inc19459JAA2NOTE 2.625% 2/1–$189.7M2.5%–––
FOLDAmicus Therapeutics, Inc.COM23,121,329$222.9M2.9%+260,000+1.1%AddedHistory
IOVAIovance Biotherapeutics, Inc.COM10,959,772$285.2M3.7%+2,307,987+26.7%AddedHistory
Retrophin Inc761299AB2NOTE 2.500% 9/1–$384.4M5.0%–––
SWTXSpringWorks Therapeutics, Inc.COM4,849,912$399.7M5.2%00.0%UnchangedHistory
BBIOBridgeBio Pharma, Inc.COM7,756,928$472.9M6.1%00.0%UnchangedHistory
MRTXMirati Therapeutics, Inc.COM3,185,898$514.6M6.7%−288,607−8.3%ReducedHistory

Options (2)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Perceptive Advisors LLC in Q2 2021
SecurityClassPutsCalls
TDOCTeladoc Health, Inc.COM–$16.6M
RAPTRAPT Therapeutics, Inc.COM$83.0K–

Sold out since Q1 2021 (17)

Positions held at the end of Q1 2021 that are gone from this filing.

Positions of Perceptive Advisors LLC sold out since Q1 2021
SecurityClassShares in Q1 2021Value in Q1 2021% of portfolio in Q1 2021History
ALLOAllogene Therapeutics, Inc.COM1,143,790$40.4M0.5%History
ARNAArena Pharmaceuticals IncCOM NEW575,007$39.9M0.5%History
ACADAcadia Pharmaceuticals IncCOM1,410,305$36.4M0.5%History
FMTXForma Therapeutics Holdings, Inc.SHS1,250,000$35.0M0.5%History
CMPSCOMPASS Pathways plcSPONSORED ADS797,404$29.4M0.4%History
PCVXVaxcyte, Inc.COM850,000$16.8M0.2%History
SNDXSyndax Pharmaceuticals IncCOM270,000$6.04M0.1%History
VINCVincerx Pharma, Inc.COM NEW300,000$5.79M0.1%History
PHRPhreesia, Inc.COM100,000$5.21M0.1%History
Deerfield Healthcare Tech Ac244413209UNIT 07/16/2025300,000$3.93M0.1%–
TXMDTherapeuticsMD, Inc.COM2,750,000$3.69M<0.1%History
VRAYViewRay, Inc.COM751,748$3.27M<0.1%History
TLISTalis Biomedical CorpCOM250,000$3.21M<0.1%History
Vincerx Pharma, Inc.92731L114*W EXP 12/24/202300,000$1.21M<0.1%–
CVMCel Sci CorpCOM PAR NEW33,700$513.0K<0.1%History
SANASana Biotechnology, Inc.COM10,000$335.0K<0.1%History
Deerfield Healthcare Tech Ac244413100COM CL A20,000$242.0K<0.1%–